Scholars Central

Conference abstractPublished 21 Oct 2013

Expression of a dominant negative HSP110 mutant by colorectal cancer cells decreases their survival and improves patient prognosis

Authors: Alex Duval

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Heat shock proteins (HSPs) are necessary for cancer cell survival. We identified a mutated form of HSP110 (HSP110DE9) in colorectal cancer displaying microsatellite instability (MSI CRC), generated from an aberrantly spliced mRNA and lacking the HSP110 substrate binding domain. This mutant is expressed at variable levels in MSI CRC cell lines and primary tumors. HSP110DE9 impaired both the normal cellular localization of HSP110 and its interaction with other HSPs, thus abrogating the chaperone activity and anti-apoptotic function of HSP110 in a dominant negative manner. HSP110DE9 over expression caused the sensitization of cells to anticancer agents such as oxaliplatin and 5-fluorouracil which are routinely prescribed in the adjuvant treatment of CRC patients. The expression level of mutant HSP110 correlates with the size of allelic deletions in the HSP110 T 17 DNA repeat located in intron 8. We recently examined a consecutive, multicentre series of 329 patients with stage II or stage III CRC whose positive MSI status was prospectively identified at diagnosis using standardized methods. Both stage II and stage III CRC patients with large HSP110 T 17 deletions and who received adjuvant chemotherapy showed excellent relapse-free survival regardless of the regimen used. Multivariate models confirmed that the survival of stage III MSI CRC patients and of chemotherapy-treated MSI CRC patients was dependent on the mutation status of HSP110 T 17 . Mutations in HSP110 T 17 thus predict the outcome of patients with MSI CRC. The likely mechanism for this association is the chemosensitization of cancer cells following the loss of HSP110 chaperone function.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Alex Duval”